The upregulation of ATP citrate lyase (ACLY) increases the expression of the resistant proteins such as ABCB1/ABCG2, making breast cancer cells resistant to docetaxel, thereby suggesting ACLY as a potential predictive biomarker of tumor recurrence in breast cancer[138]. Here, ABCB1 is linked to breast carcinoma.